Cancers Related Viruses: Immunology, Immunogenetics, Immunotherapies

Cancer is the leading public health problem of the 21st century, with nearly 1.4 million new cases attributed to viral infections, accounting for 8% of all cancer cases. Seven viruses are classified as carcinogenic to humans: HPV, HBV, HCV, EBV, KSHV, and HTLV-1, each of which can cause multiple cancers. The difficulty in finding effective treatments for these different types of cancers highlights the need to develop new therapeutic approaches. To achieve this goal, understanding the tumor microenvironment, the modulation of gene expression by viral oncoproteins, and the modulation of the immune response aimed at tumor escape are crucial for the development of more effective advanced therapies targeting tumors.In this context, this Research Topic will present studies that aim to provide insight into the current state of understanding of viral oncogenesis, as well as the development of new therapeutic approaches for these cancers.To achieve this goal, this special volume will accept manuscripts focused on the following topics:- Immunology of the tumor microenvironment;- Immunogenetics addressing tumor development and/or control;- Immunoinformatics applied to cancer diagnosis and/or therapy;- Cancer immunotherapy (DNA/mRNA vaccines, dendritic cell vaccines, vectored vaccines, whole-cell vaccines)- Drug delivery systems or anti-cancer vaccines Topic editors: Antonio Freitas, Aldo Venuti, Anna Duarte Source: https://www.frontiersin.org/research-topics/74278/cancers-related-viruses-immunology-immunogenetics-immunotherapies